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SUMMARY
Inducible bronchus-associated lymphoid tissue
(iBALT) is an ectopic lymphoid structure composed
of highly organized T cell and B cell zones that forms
in the lung in response to infectious or inflammatory
stimuli. Here,wedevelopamodel for fungal-mediated
iBALT formation, using infection with Pneumocystis
that induces development of pulmonary lymphoid
follicles. Pneumocystis-dependent iBALT struc-
ture formation and organization required CXCL13
signaling. Cxcl13 expression was regulated by inter-
leukin (IL)-17 family members, as Il17ra/, Il17rb/,
and Il17rc/ mice failed to develop iBALT. Interest-
ingly, Il17rb/ mice have intact Th17 responses,
but failed to generate an anti-Pneumocystis Th2
response. Given a role for Th2 and Th17 immunity
in iBALT formation, we demonstrated that primary
pulmonary fibroblasts synergistically upregulated
Cxcl13 transcription following dual stimulation with
IL-13 and IL-17A in a STAT3/GATA3-dependent
manner. Together, these findings uncover a role for
Th2/Th17 cells in regulating Cxcl13 expression and
provide an experimental model for fungal-driven
iBALT formation.
INTRODUCTION
Inducible bronchus-associated lymphoid tissues (iBALT) are
ectopic lymphoid structures that form in the lung in response
to a variety of infectious stimuli (Foo and Phipps, 2010; Pitzalis
et al., 2014). iBALT structures mirror the organization of second-
ary lymphoid organs (SLO), as both have distinctive T and B cell
zones with proliferating lymphocytes (Cyster, 2003; Foo and
Phipps, 2010; Randall, 2010). iBALT has been shown previously
to provide enhanced protection and confer increased survival to
influenza in mice lacking SLOs (Moyron-Quiroz et al., 2004,
2006). Several key soluble mediators implicated in SLO develop-
ment also have critical roles in iBALT formation. Members of the
homeostatic chemokine family, CXCL13 (a ligand for CXCR5)
and CCL19/CCL21 (ligands for CCR7) have been shown to
facilitate iBALT organization (Cyster, 2003; Kocks et al., 2007;
Rangel-Moreno et al., 2006). Interestingly, despite production
by dendritic cells, these chemokines appear to be predominantly
produced by local pulmonary non-hematopoietic cell popula-
tions in response to influenza (GeurtsvanKessel et al., 2009; Ran-
gel-Moreno et al., 2007).
Two other factors, lymphotoxin-alpha (LTa) and interleukin
(IL)-17A, have been implicated previously as upstream drivers
of Cxcl13 expression. Mice deficient in LTa fail to develop
SLOs, have a disorganized splenic architecture, and likewise
have unorganized iBALT structures (Moyron-Quiroz et al.,
2004, 2006; De Togni et al., 1994). LTa and CXCL13 are part of
a positive feedback loop, where CXCL13 signaling through
CXCR5 induces LTa, while LTa signaling through LT-bR induces
more CXCL13 (Bracke et al., 2013; Litsiou et al., 2013). Addition-
ally, it has been previously shown that IL-17A is required
for iBALT formation using a neonatal LPS/influenza challenge
models (Rangel-Moreno et al., 2011). Furthermore, neonatal pul-
monary fibroblasts treated with IL-17A upregulate expression of
Cxcl13 (Rangel-Moreno et al., 2011). The finding that iBALT
forms more easily in neonate mice appears to have a human
correlate, as infants and young children have iBALT structures
at a higher frequency than healthy adults (Emery and Dinsdale,
1973; Tschernig et al., 1995). However, patients with conditions
associated with chronic pulmonary inflammation (e.g., asthma,
chronic obstructive pulmonary disease) appear to promote
iBALT formation (Elliot et al., 2004; John-Schuster et al., 2014).
Pneumocystis jirovecii remains a common opportunistic
infection in patients with immunodeficiencies (e.g., genetic or
AIDS) or receiving immunosuppressive drug regimens as ther-
apy (e.g., autoimmune conditions, hematologic malignancy,
post-transplantation rejection) (Eddens and Kolls, 2015; Maini
et al., 2013; Mikaelsson et al., 2006; Morris et al., 2004a). How-
ever, the ubiquitous nature of Pneumocystis exposure in the
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immunocompetent population may also have pathologic conse-
quences. For example, one study found that the majority of
healthy children by the age of 6 had detectable anti-Pneumocys-
tis antibodies (Respaldiza et al., 2004). Furthermore, using mo-
lecular techniques, Vargas et al. (2013) demonstrated that nearly
all infants by the age of 3 months had Pneumocystis present in
their lungs. Colonization with Pneumocystis in these infants
was associated with increases in a chloride channel associated
with mucus release, suggestive of potential pathologic response
to the fungus (Pe´rez et al., 2014). Likewise, we have previously
demonstrated that Pneumocystis exposure in mice led to
asthma-like pathology, and a subset of patients with severe
asthma had increased antibody responses against Pneumocys-
tis (Eddens et al., 2016).
Given the previous findings connecting asthma to Pneumo-
cystis, as well as asthma to iBALT, we sought to examine a po-
tential relationship between Pneumocystis and iBALT formation.
Here, we demonstrate that infection and exposure with Pneu-
mocystis induces a protective, robust formation of iBALT in
a CXCL13-dependent manner, while LTa was required for
germinal center development. Furthermore, both Th2 and Th17
cells induced by Pneumocystis infection were required for
optimal Cxcl13 induction and iBALT formation. Finally, we
demonstrate that IL-17A and IL-13 synergistically regulate
Cxcl13 expression in pulmonary fibroblasts using a STAT3-
and GATA3-dependent pathway, respectively.
RESULTS
Inducible Bronchial-Associated Lymphoid Tissue
Develops following Pneumocystis Infection and
Exposure
Over the course of murine Pneumocystis infection, we observed
small but distinctive perivascular lymphocytic accumulations
with an iBALT appearance at day 7 post-infection (Figure 1A).
These ectopic structures continued expanding by day 14 post-
infection and subsequently contracted by day 28 (Figure 1A).
The lymphocytic follicles were equipped with peripheral node
addressin+ (PNAd+) high endothelial venules outside the
lymphoid follicles, which are likely supporting attraction and re-
circulation of CD62L+ naive and central memory T cells (Fig-
ure 1B). Furthermore, lymphatic vessel endothelial hyaluronan
receptor 1 (Lyve-1+) lymphatic vessels were also present in the
surrounding areas of the follicle (Figure 1B). Importantly the
formation of iBALT following Pneumocystis infection was not
an artifact of oropharyngeal infection with a large inoculum.
C57BL/6 mice co-housed with a Pneumocystis infected
Rag2/Il2rg/ double knockout mouse for 2 weeks also had
formation of perivascular follicles 4 weeks post-exposure (Fig-
ure 1C). Formation of iBALT following co-housing required adap-
tive immunity, as Rag1/ mice did not have lymphoid follicles
following co-housing (Figure 1C). Interestingly, both C57BL/6
and Rag1/ mice co-housed with an infected Rag2/Il2rg/
mouse had detectable Pneumocystis burden 4 weeks removed
from exposure, confirming both the aerial transmission and sus-
tained infection by Pneumocystis (Figure 1D).
We next sought to characterize the lymphoid populations con-
tained within the structures. A classic cellular component of
iBALT structures are B cells that are progressively experiencing
changes in their phenotype, ranging from small naive B cells to
more activated large proliferating germinal center B cells. In
C57BL/6 mice inoculated with Pneumocystis oropharyngeally,
iBALT structures contained large, proliferating cell nuclear anti-
gen (PCNA)-positive BB20Lo B cell blasts as well as inter-
and intra-follicular CD3+ T cells (Figure 1E). Although PNA non-
specifically binds to carbohydrates found within the alveolar
spaces, large PNA+B220Lo blasts are present within germinal
centers (Figures 1E and S1). CD4+ T cells are crucial for the
development of these structures, as depletion with an anti-
CD4 monoclonal antibody (GK1.5) completely abrogated the or-
ganization of the B cell follicles and impaired the accumulation
and proliferation of activated B cells (Figure 1F). Likewise, deple-
tion of B cells with an anti-CD20 monoclonal antibody (5D2) dis-
rupted organization in the iBALT structures (Figure 1G). Morpho-
metric analysis of these iBALT structures demonstrated that
both CD4+ and CD20+ depletion resulted in the reduction of
lymphoid follicle size, number, and area occupied per lung sec-
tion (Figure 1H).
Fungal exposure of any species was not sufficient to induce
iBALT, as Aspergillus-infected mice did not have lymphoid folli-
cles in the lung 14 days post-infection (Figure S2A). At this time
point, Aspergillus burden was undetectable, as were any resid-
ual inflammatory changes (Figure S2B). Together, these results
suggest that Pneumocystis may be a unique fungal pathogen
capable of stimulating iBALT formation as a result of unique mo-
lecular patterns or the chronicity of the infection.
Effector CD4+ T Cells from iBALT Structures Provide
Protection against Pneumocystis Infection
To define the protective role of the iBALT structures in ourmodel,
CD4+ T cells were isolated from the lung, the mediastinal lymph
node (mLN), and spleen at day 14 post-infection and were adop-
tively transferred into a Pneumocystis-infected Rag1/ mouse
(Figure 2A). Fourteen days following transfer, CD4+ T cells from
the spleen, mLN, and iBALT structures were all capable of
reducingPneumocystis burden by 10-fold compared to no trans-
fer controls (Figure 2B). Transferred splenic, mLN, and iBALT
CD4+ T cells significantly induced transcription of effector cyto-
kines such as Ifng, Il13, and Il17a within the lung (Figure 2C).
Interestingly, mLN appeared to have the highest transcription
of Il13, while production of Ifng and Il17a was similar among
groups (Figure 2C). These results demonstrate that like other
conventional T cell populations in the spleen and mLN, iBALT
CD4+ T cells are capable of providing protection against Pneu-
mocystis infection.
Lymphotoxin-alpha and CXCL13 Are Required for
Pneumocystis-Driven iBALT Maturation
Lymphotoxin-alpha (LTa) has been previously implicated as
an upstream mediator in the production of homeostatic chemo-
kines that are critical in iBALT formation in response to influenza
infection (Rangel-Moreno et al., 2011) and as an inducer of
Cxcl13 production following smoke exposure in mice (Demoor
et al., 2009). In Lta/ mice infected with Pneumocystis, the
cellular characterization of iBALT structures by immunofluo-
rescence showed small proliferating B cells and lacked
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PCNA+B220lo germinal center B cells compared to C57BL/6
mice (Figure 3A). Additionally, we detected infiltrating CD4+
T cells within the disorganized follicles in Lta/mice (Figure 3B).
Despite the lack of functional organization, iBALT structures in
Lta/ mice were larger, more numerous, and consumed more
area of lung parenchyma compared toC57BL/6mice (Figure 3C).
Unexpectedly, despite the interruption of the positive feedback
loop between homeostatic chemokines and LTa, Lta/ mice
had comparable levels of Cxcl13 production compared to
C57BL/6 mice (Figure 3D). T cell responses, as measured by
Pneumocystis-specific interferon (IFN)-g, IL-5, and IL-17A pro-
duction, were preserved in Lta/ mice (Figure S3A). However,
consistent with the lack of germinal centers, Lta/ mice had
defective anti-Pneumocystis IgG in the serum, comparable to
that of CD4+ T cell-depleted mice (Figure 3E). Despite defective
humoral immunity, Lta/ mice were still able to clear Pneumo-
cystis at day 14 post-infection like C57BL/6 mice (Figure 3F).
Much like LTa, ligands for both CXCR5 (CXCL13) and CCR7
(CCL19 and CCL21) have previously been implicated in the
formation and compartmentalization of secondary lymphoid
organ and iBALT formation in both mice and humans (Bracke
et al., 2013; GeurtsvanKessel et al., 2009; Rangel-Moreno
et al., 2007). Over the course of Pneumocystis infection,
Cxcl13, but not Ccl19 or Ccl21, was induced in a concomitant
manner to iBALT formation (Figure 4A) Importantly, Cxcl13 in-
duction was absent in GK1.5-treated mice, suggesting CD4+
T cells regulate expression of this chemokine (Figure 4A). Like-
wise, C57BL/6 wild-type mice that developed iBALT following
exposure to a Pneumocystis-infected Rag2/Il2rg/ mouse
had increased Cxcl13, but not Ccl19 or Ccl21 expression (Fig-
ure 4B). Cells of the adaptive immune system were also
required for optimal Cxcl13 expression following co-housing
with a Pneumocystis-infected Rag2/Il2r/ mouse, as co-
housed Rag1/ mice failed to upregulate the chemokine
Figure 1. Inducible Bronchus-Associated Lymphoid Tissue Forms following Pneumocystis Infection and Exposure
(A) Inducible bronchus-associated lymphoid tissue (iBALT) development over the course of Pneumocystis infection.
(B) Immunofluorescent staining of an iBALT structure 14 days post-infection with Pneumocystis demonstrating the presence of PNAd+ high endothelial venules
and Lyve-1+ lymphatic vessels.
(C) C57BL/6 mice co-housed for 2 weeks with a Pneumocystis infected Rag2/Il2rg/ mouse have iBALT structures 4 weeks following separation, while
similarly co-housed Rag1/ mice do not.
(D) C57BL/6 and Rag1/ mice co-housed for 2 weeks with a Pneumocystis infected Rag2/Il2rg/ mouse have detectable Pneumocystis burden.
(E) Immunofluorescent staining of rapidly dividing B cells (PCNA+B220+) cells and CD3+ T cells in the lung of a C57BL/6 mouse 14 days after Pneumocystis
infection.
(F) iBALT structures are reduced following CD4+ T cell depletion with GK1.5 monoclonal antibody.
(G) iBALT structures are reduced following CD20+ B cell depletion with 5D2 monoclonal antibody. Scale bars, 100 mm.
(H) Quantification of iBALT structures in C57BL/6 mice, C57BL/6 mice treated with GK1.5, and C57BL/6 mice treated with 5D2 (n = 4 per group). Data are shown
as mean ± SEM. *p < 0.05, **p < 0.01, ****p < 0.0001 by one-way ANOVA with Tukey’s multiple comparisons.
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(Figure 4B). Further implicating CXCL13 as a crucial mediator of
Pneumocystis iBALT formation and organization, Cxcr5/
mice lacked organized follicles containing T cell and B cells
zones in the lung 14 days post-infection (Figure 4C). Consistent
with the key role for CXCL13 in the attraction of CXCR5+ B
cells, there were very few B cells within the follicles in IBALT
areas of Cxcr5/ mice (Figure 4D). Interestingly, despite the
paucity of organization in Cxcr5/ mice, the size, number,
and area consumed by inflammatory infiltrates were compara-
ble to that of C57BL/6 mice (Figure 4E). Surprisingly, despite
the lack of draining lymph nodes and the presence of
poorly organized iBALT structures, Cxcr5/ mice had an intact
humoral immune response and produced anti-Pneumocystis
IgG (Figure S3B). However, CD4+ T cells from the lungs of
Cxcr5/ mice had greater Pneumocystis-specific IFN-g and
impaired production of IL-5 compared to C57BL/6 mice
(Figure S3C). Despite subtle changes in T cell phenotype,
Cxcr5/ mice were capable of clearing Pneumocystis infec-
tion by day 14 post-infection (Figure 4F). Together, these
findings demonstrate a role for LTa and CXCR5 in germinal
center formation and iBALT organization, independently
of the induction of protective pulmonary immunity against
Pneumocystis.
Pneumocystis iBALT Is Dependent on CD4+ Th2 and
Th17 Cells
As the observed increase in Cxcl13 expression was CD4+ T cell-
dependent, we next characterized the T-helper responses to
Pneumocystis infection at day 7 post-infection, prior to signifi-
cant Cxcl13 mRNA induction. Mice infected with Pneumocystis
had significant increases in both IL-17A and IL-13 single-pro-
ducing, as well as IL-17A+IL-13+ double-producing ab CD4+
T cells compared to naive controls (Figures S4A–S4D). Innate
lymphoid cells and gd T cells appeared to be minor contributors
of both IL-17A and IL-13 (Figures S4A–S4C). Likewise, at day 7
post-infection, no significant induction of Il17a and Il13 transcript
was noted in Rag1/ or Rag2/Il2rg/ mice, further confirm-
ing the predominant role of T-helper cells as cytokine producers
(Figure S4E). The hallmark cytokine of Th1 cells, interferon-g,
was only modestly induced (data not shown).
Additionally, at day 14 post-infection, ab CD4+ T cells greatly
outnumbered both innate lymphoid cells and gd T cells in the
lungs (Figure S4F). Furthermore, gd T cells appeared to be sec-
ondary contributors to iBALT formation, as Tcrd/ mice devel-
oped large lymphoid follicles at day 14 post-infection (Fig-
ure S4G). Together, these findings suggest that Th2 and Th17
cells accumulate in the lung following Pneumocystis infection
Figure 2. CD4+ T Cells from the Spleen, Mediastinal Lymph Node, and iBALT Structures Are Protective against Pneumocystis Infection
(A) Schematic representation of isolation of spleen, mediastinal lymph node (mLN), and iBALT CD4+ T cells at day 14 post-Pneumocystis infection, followed by
adoptive transfer into a previously infected Rag1/ mouse.
(B) Transfer of splenic, mLN, and iBALT CD4+ T cells reduces Pneumocystis burden compared to no transfer (PBS) control.
(C) Expression of Ifng, Il13, and Il17a in whole lung following transfer of CD4+ T cells from spleen, mLN, and iBALT demonstrating preserved effector function in
each population. Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA with Tukey’s multiple comparisons.
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and are the primary cytokine producers starting at day 7 post-
infection.
Given the robust Th17 response, we next evaluated the contri-
bution of IL-17 receptor family members, IL-17RA, IL-17RB, and
IL-17RC, in Pneumocystis-driven iBALT formation. IL-17A sig-
nals through a heterodimeric complex of IL-17RA and IL-17RC,
while the Th2-promoting cytokine IL-25 (IL-17E) signals through
IL-17RA and IL-17RB (Gaffen, 2009; Rickel et al., 2008). IL-17A
has been previously implicated in triggering bothCxcl13 produc-
tion and iBALT formation after LPS instillation into neonatal mice
and during experimental infection with influenza viruses and
Mycobacterium tuberculosis (Gopal et al., 2013; Rangel-Moreno
et al., 2011). Similar to those models, Pneumocystis-driven
iBALT was disrupted in Il17ra/ mice compared to wild-type
controls, as Il17ra/ mice had drastic reductions in PCNA+-
B220+ cells and showed little organization in iBALT structures
(Figure 5A). Surprisingly, iBALT formation was severely compro-
mised in Il17rb/ mice following Pneumocystis infection (Fig-
ure 5A). Likewise, Il17rc/ mice had a reduction in iBALT size
and poor cellular organization (Figure 5A). Upon quantification,
Il17ra/, Il17rb/, and Il17rc/ mice all had significantly
reduced follicle number and average size, as well as area occu-
pied within the lung (Figure 5B). In concordance with the histo-
logic data, Il17ra/, Il17rb/, and Il17rc/ mice had reduced
expression of Cxcl13 in the infected lung (Figure 5C). Consistent
with a role for IL-25 in type II immune responses, Il17ra/ and
Il17rb/ mice both had diminished expression of Il5 and Il13
expression and IL-4 production following ex vivo stimulation
with Pneumocystis antigen (Figures S5A and S5B). Il17rc/
mice had Th2 cytokine expression and production comparable
to that of C57BL/6 mice, suggestive of intact Th2 priming
and differentiation (Figures S5A and S5B). Production of Il17a
Figure 3. Lymphotoxin-alpha Is Required for iBALT Organization and Germinal Center Development following Pneumocystis Infection
(A) Immunofluorescent staining of C57BL/6 and Lta/ mice 14 days following Pneumocystis infection demonstrating a lack of PCNA+B220lo germinal center
B cells in Lta/ mice compared to C57BL/6 mice. Scale bars, 100 mm.
(B) Immunofluorescent staining of C57BL/6 and Lta/ mice demonstrating intrafollicular CD3+ T cells. Scale bars, 100 mm.
(C) Quantification of size, number, and area occupied by iBALT structures (n = 7–8). ***p < 0.001, ****p < 0.0001 by Student’s t test.
(D) Expression of Cxcl13 is similar between C57BL/6 and Lta/ mice in whole lung (n = 7).
(E) Lta/ mice have deficient production of serum anti-Pneumocystis-specific IgG compared to C57BL/6 mice (n = 4–6).
(F) Lta/ mice sufficiently clear Pneumocystis infection comparable to that of C57BL/6 controls (n = 3–7). Data are shown as mean ± SEM. **p < 0.01,
***p < 0.001, ****p < 0.0001 by one-way ANOVA with Tukey’s multiple comparisons.
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and Ifng was largely unchanged among the various genotypes
(Figure S5A).
As both Il17ra/ and Il17rb/ mice had reduced lymphoid
follicle development and defective Th2 responses, we next
sought to confirm the role of the IL-17RB ligand, IL-25, in iBALT
formation. C57BL/6 mice were treated with an anti-IL25
monoclonal antibody prior to fungal infection. At day 14 post-
infection with Pneumocystis, anti-IL25 treatment substantially
reduced lung inflammation, as well as the structural organiza-
tion of iBALT (Figures S6A and S6B). Both the size and total
area occupied by iBALT follicles were also reduced following
anti-IL25 treatment, while number of lymphoid follicles was
unchanged (Figure S6C). Taken together, these results suggest
that Il17ra/ and Il17rb/ mice appear to have defective
Th2 priming and iBALT formation due to defective IL-25
signaling.
As we have shown previously that eosinophils are a protective
downstream mediator of the Th2 response following Pneumo-
cystis infection (Eddens et al., 2015), we next examined the
expression of the eosinophil marker major basic protein (Prg2)
in the lungs. Both Il17ra/ and Il17rb/ had significantly
reduced expression of Prg2 similar to that of CD4-depleted ani-
mals, again demonstrating functional impairment of Th2 re-
sponses in these mice (Figure 5D). Il17rc/ mice, on the con-
trary, had similar eosinophil recruitment compared to C57BL/6
mice (Figure 5D). Strikingly, Il17ra/ mice had Pneumocystis
burden levels comparable to that of CD4-depleted mice sugges-
tive of a synergy between Th2 and Th17 responses, while both
Il17rb/ and Il17rc/ had trends toward increased burden at
day 14 post-infection (Figure 5E).
Further supporting the role of Th2 cells in development of
fungal iBALT, Stat6/ mice had dramatically reduced lymphoid
Figure 4. CXCR5 Signaling Is Required for Pneumocystis iBALT Formation
(A) Cxcl13 is induced over the course of Pneumocystis infection in C57BL/6 mice in a CD4+ T cell-dependent manner. Ccl19 and Ccl21 expression levels are
unchanged throughout Pneumocystis infection. *p < 0.05 by multiple t tests, (n = 5 per group).
(B) C57BL/6 mice co-housed with a Pneumocystis infected Rag2/Il2rg/ mouse for 2 weeks, followed by 4 weeks of separation, upregulate Cxcl13 but not
Ccl19 or Ccl21 (n = 3–6 per group). *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA with Tukey’s multiple comparisons.
(C) Immunofluorescent staining ofCxcr5/mice shows disorganized follicles lacking T cell and B cell zones compared to C57BL/6 mice following Pneumocystis
infection. Scale bars, 100 mm.
(D) Cxcr5/ mice have disorganized B cell follicle structure after Pneumocystis infection compared to C57BL/6 mice. Scale bars, 100 mm.
(E) Quantification of size, number, and area occupied by lymphocytic infiltrates (n = 7–8).
(F) C57BL/6 (n = 10) and Cxcr5/ (n = 4) control Pneumocystis burden at 14 days post-infection compared to CD4-depleted mice (n = 6). Data are shown as
mean ± SEM. ***p < 0.001, ****p < 0.0001 by one-way ANOVA with Tukey’s multiple comparisons.
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follicle development on H&E staining compared to BALB/c con-
trols (Figure S7A).Stat6/mice had reduced Il13mRNA expres-
sion compared to BALB/c mice, while Il17a transcription levels
were similar (Figure S7B). Likewise, C57BL/6 mice treated with
a monoclonal antibody against IL-13 had noticeable disruption
in iBALT structures compared to controls (Figure S7C). IL-13
neutralization was effective, asmeasured by the functional ability
to block Muc5ac expression (Figure S7D). Importantly, IL-13
blockade did not impact transcription of Il13 or Il17a (Figure S7D)
but did result in increased Pneumocystis burden (Figure S7E).
Altogether, these results demonstrate that disruption of either
the Th2 or Th17 responses alone was capable of reducing Pneu-
mocystis iBALT formation.
Despite the influence of Th2 cells on iBALT formation, eosin-
ophils did not seem to actively participate in the formation
of iBALT, as dblGATA1/ (on a BALB/c background) mice
formed lymphoid follicles and expressed Cxcl13 in a manner
similar to that of BALB/c control mice (Figures S7F and S7G).
Furthermore, in agreement with previously published data in
a sterile Pneumocystis antigen model (Eddens et al., 2016),
the T cell responses were unperturbed in dblGATA1/ mice
(Figure S7G).
IL-13 and IL-17A Synergistically Induce CXCL13
Production
Formation of Pneumocystis-driven iBALT is dependent on
CXCL13 production, but surprisingly both mice lacking IL-17
signaling and Th2 cell polarization have defectiveCxcl13 expres-
sion. To determine the cellular sources of CXCL13, lung blood
endothelial cells (CD45CD31+podoplanin), triple negative
SLO cells (CD45CD31podoplanin), lymphatic endothelial
cells (CD45CD31+podoplanin+), and pulmonary fibroblasts
(CD45CD31podoplanin+) were sorted from the lung at day
14 post-infection (Fletcher et al., 2011). All of these cell popula-
tions demonstrated significant increases in Cxcl13 expression,
with pulmonary fibroblasts representing the largest relative
contributor (Figure 6A). Importantly, the hematopoietic compart-
ment (CD45+) did not increase Cxcl13 expression following
Pneumocystis infection (Figure 6A). Pulmonary fibroblasts, as
well as the endothelial cells populations, all had high relative ex-
pressions of the receptor components for IL-13 (Il4r and Il13ra1)
and IL-17A (Il17ra and Il17rc) (Figure 6B). To determine the
spatial location of CXCL13 producing cells, we performed immu-
nofluorescence in lungs of mice infected with Pneumocystis.
CXCL13 protein was located within the center of the lymphoid
Figure 5. IL-17R Family Members Are Required for the Development of Pneumocystis iBALT
(A) Representative immunofluorescent staining of C57BL/6, Il17ra/, Il17rb/, and Il17rc/ mice, respectively, 14 days following Pneumocystis infection
demonstrates decreased iBALT formation (top). Il17ra/, Il17rb/, and Il17rc/mice all have reduced proliferating B cells (middle) and disorganized T cell and
B cell zones (bottom). Scale bars, 100 mm.
(B) Quantification of size, number, and area occupied by iBALT structures.
(C) Cxcl13 expression is reduced in whole lung tissue of Il17ra/, Il17rb/, and Il17rc/ mice (n = 8–16).
(D) Eosinophil recruitment as measured by Prg2 expression is diminished in Il17ra/ and Il17rb/ mice (n = 8–16).
(E) Il17ra/mice have increased Pneumocystis burden comparable to that of CD4-depleted animals, while Il17rb/ and Il17rc/ have a trend toward increased
burden (n = 4–12). Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ****p < 0.0001 by one-way ANOVA with Tukey’s multiple comparisons.
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follicles and was undetectable in the airway epithelium and
vascular endothelium (Figure 6C). Another known producer of
CXCL13, CD21+CD35+FDC-M1+ follicular dendritic cells, were
also absent in the Pneumocystis-driven follicles (data not
shown). These histologic findings, coupled with high Cxcl13
expression in podoplanin-positive cells, suggest that pulmonary
fibroblasts are a primary cellular source of CXCL13.
To that end, we hypothesized that Cxcl13 expression in pul-
monary fibroblasts was being driven by IL-17 and/or the local
type II cytokine responses in the lung. Cultured primary pulmo-
nary fibroblasts from adult mice responded to both IL-17A and
IL-13 6 hr following stimulation, as the respective conditions
led to upregulation of Cxcl1 and Ccl11 (Figure 6D). However,
Cxcl13 was not induced 6 hr following stimulation with IL-17A,
IL-13, or the combination of the two cytokines (Figure 6D). At
24-hr post-stimulation, Cxcl13 was significantly upregulated in
fibroblasts treated with both IL-17A and IL-13 compared to
single stimulation controls (Figure 6E). Cxcl1 induction at this
time point had waned, while Ccl11 expression remained high
in IL-13-treated cells (Figure 6E).
The direct induction of Cxcl1 by IL-17A coupled with the de-
layed induction ofCxcl13, led us to hypothesize an indirect effect
of IL-17A was synergizing with IL-13. Stimulation of pulmonary
fibroblasts with IL-17A for 6 hr induced a 4-fold increase in
IL-6 production (Figure 7A). Interestingly, IL-6 coupled with
IL-13 induced similar levels of Cxcl13 expression compared to
IL-13 and IL-17A co-stimulated cells (Figure 7B). To further
demonstrate a role for IL-17A-induced IL-6 in Cxcl13 mRNA
expression, we found that blockade of gp130 attenuated the
Cxcl13 induction following stimulation with IL-17A and IL-13
(Figure 7C). STAT3, a downstream target of IL-6, was required
for Cxcl13 induction, as Stat3fl/fl fibroblasts treated with adeno-
virus-Cre-GFP (Ad-Cre) failed to increase Cxcl13 transcription
with either IL-17A/IL-13 or IL-6/IL-13 stimulation (Figure 7D).
Similarly, canonical IL-13 signaling requires both activation
of STAT6 and GATA3. To that end, Stat6/ fibroblasts failed
Figure 6. IL-17A and IL-13 Synergistically Regulate Cxcl13 Expression in Pulmonary Fibroblasts
(A) Expression of Cxcl13 in sorted lung populations, including CD45 lung blood endothelial cells (CD31+podoplanin), triple negative SLO cells
(CD31podoplanin), lymphatic endothelial cells (CD31+podoplanin+), pulmonary fibroblasts (CD31podoplanin+), andCD45+ cells at day 14 post-Pneumocystis
infection (n = 4). Cxcl13 is induced in the CD45 cell populations with CD31podoplanin+ fibroblasts representing the largest relative contributor.
(B) The receptors for IL-13 (Il4r and Il13ra1) and IL-17A (Il17ra and Il17rc) are expressed in each cell population. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s
t test.
(C) Immunofluorescent staining demonstrates CXCL13 protein within the lymphoid follicle 14 days post-infection with Pneumocystis. Scale bars, 100 mm.
(D) Pulmonary fibroblasts upregulate Cxcl1 and Ccl11 following a 6-hr stimulation with 100 ng of IL-17A and various doses of IL-13 (in ng), respectively. Cxcl13
expression is unchanged in all conditions at 6 hr post-stimulation (n = 4).
(E)Cxcl1 expression is reduced at 24 hr post-stimulation, whileCcl11 expression persists. Stimulation with both IL-17A and IL-13 leads to upregulation ofCxcl13
at 24 hr post-stimulation (n = 2–4). Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by one-way ANOVA with Tukey’s multiple
comparisons.
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to induce Cxcl13 following stimulation with IL-17 and IL-13
compared to C57BL/6 controls (Figure 7E). Likewise, Gata3fl/fl
fibroblasts treated with Ad-Cre did not have upregulation of
Cxcl13 following dual stimulation (Figure 7F). Strikingly, these
findings demonstrate an indirect role of IL-17A in activating
STAT3 and a direct role of IL-13, STAT6, and GATA3 signaling
in inducing Cxcl13 expression in pulmonary fibroblasts.
DISCUSSION
The current study demonstrates that Pneumocystis infection via
either oropharyngeal inoculation or natural transmission results
in induction of CXCL13 and iBALT formation. Furthermore, the
Pneumocystis-dependent iBALT structures required signaling
through IL-17 family members for optimal iBALT formation/orga-
nization, and mice with either defective Th17 or Th2 responses
failed to induce CXCL13 expression and develop iBALT. Finally,
pulmonary fibroblasts from adult mice stimulated with both IL-
17A and IL-13 synergistically upregulate CXCL13 expression in
a STAT3- and GATA3-dependent manner.
Importantly, this study identifies a fungal pathogen capable of
inducing iBALT. Previously studied models include bacterial
(Pseudomonas) and viral (influenza, modified vaccinia virus An-
kara [MVA]), and subtle differences have begun to emerge in
iBALT formation depending on the pathogen of interest (Fleige
et al., 2014; GeurtsvanKessel et al., 2009; Halle et al., 2009;
Moyron-Quiroz et al., 2004). For example, Pseudomonas-driven
iBALT formation requires CXCL12-producing stromal cells, while
MVA induces iBALT through a CXCL13-producing follicular den-
dritic cell-dependent mechanism (Fleige et al., 2014). Likewise,
Figure 7. Cxcl13 Expression Is Dependent on STAT3 and GATA3 Activation
(A) Expression of Il6 is upregulated in pulmonary fibroblasts following a 6-hr stimulation with IL-17A (n = 4).
(B) Cxcl13 is induced in pulmonary fibroblast by 24 hr stimulation with IL-13 in combination with either IL-6 or IL-17A (n = 4–10).
(C) Cxcl13 upregulation is partially blocked by treatment with an anti-gp130 antibody (n = 7–9).
(D) Cxcl13 expression is attenuated in pulmonary fibroblasts from Stat3fl/fl mice following in vitro treatment with adenovirus-Cre (n = 4–12).
(E) Stat6/ fibroblasts fail to upregulate Cxcl13 following stimulation with IL-17A and IL-13 (n = 3-6).
(F) Cxcl13 expression is attenuated in pulmonary fibroblasts from Gata3fl/fl mice following in vitro treatment with adenovirus-Cre (n = 3–4). Data are shown as
mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by one-way ANOVA with Tukey’s multiple comparisons.
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CXCL13 expression has been implicated in influenza-mediated
iBALT formation (GeurtsvanKessel et al., 2009; Moyron-Quiroz
et al., 2004; Rangel-Moreno et al., 2007). However, unlike
MVA infection, CXCL13 expression in response to influenza is
mediated primarily by a stromal, and not hematopoietic, source
(Rangel-Moreno et al., 2007). Influenza-mediated iBALT requires
additionally soluble factors, such as lymphotoxin-alpha, for
development. Blockade of the receptor for lymphotoxin-alpha
(LTbR) was sufficient to reduce influenza-driven iBALT and
neonatal Lta/ mice exposed to LPS followed by a sub-
sequent challenge with influenza failed to develop iBALT
(GeurtsvanKessel et al., 2009; Rangel-Moreno et al., 2011). In
our model of Pneumocystis infection, lymphotoxin-alpha and
CXCL13 are required for optimal T and B cell compartmentaliza-
tion and germinal center formation. These findings further high-
light the need to study iBALT in a pathogen-specific manner,
as differences in mechanism may arise from unique molecular
properties for each pathogen.
Furthermore, despite the requirement for CXCL13 in both the
neonatal LPS-influenza and Pneumocystis models, the mecha-
nism of Cxcl13 transcript induction appears to be different. Ran-
gel-Moreno et al. (2011) demonstrated that neonatal pulmonary
fibroblasts upregulate Cxcl13 expression following stim-
ulation with IL-17A. However, in adult pulmonary fibroblasts,
IL-17A stimulation does not appear to be sufficient to upregulate
Cxcl13. Surprisingly, IL-13 and IL-17A, products of the mixed
Th2 and Th17 inflammatory response generated by Pneumocys-
tis, potently induce Cxcl13 expression in adult pulmonary fibro-
blasts. The mechanism of IL-13 and IL-17A synergy appears to
be dependent on the hallmark downstream transcription factors,
STAT3 and GATA3. These findings suggest that transcriptional
regulation of Cxcl13 is tightened over the course of develop-
ment, perhaps through epigenetic modifications. Alternatively,
it is possible that neonatal fibroblasts have a lower threshold
for the activation either STAT3 or GATA3.
Interestingly, STAT3 ligands have been implicated previously
in inducing Cxcl13 expression and initiating iBALT formation.
Using transgenic mice expressing both human IL-6 and IL-6R,
Goya et al. (2003) were able to elegantly demonstrate that
CXCL13-positive lymphoid follicles spontaneously form in the
lung. iBALT formation using transgenic lines have not been
limited to STAT3 ligands, however. Mice overexpressing IL-5, a
Th2 cytokine responsible for eosinophilopoiesis, similarly
develop spontaneous iBALT structures in addition to asthma-
like pathology (Lee et al., 1997). Of course, these mice recapitu-
late models of chronic stimulation with each cytokine irrespec-
tive of an infectious stimulus.
One unique aspect of this fungal-driven iBALT model is the
synergistic nature of both Th17 and Th2 cells over the course
of 14 days of infection. Strikingly, mice lacking both IL-17A
signaling (Il17ra/ and Il17rc/) and IL-25 signaling (Il17ra/
and Il17rb/) failed to upregulate Cxcl13 and subsequently
develop iBALT. Although IL-17A signaling has previously been
implicated in iBALT formation (Gopal et al., 2013; Rangel-Mor-
eno et al., 2011), Il17rb/ mice with intact IL-17A responses,
but defective production of Il5 and Il13, failed to form iBALT.
Furthermore, blockade of IL-13 signaling in vivo and Stat6/
mice had reduced iBALT formation following Pneumocystis
infection. Importantly, IL-13 was produced solely by TCRb+ cells
and not ILC2s, similar to previous findings in a Pneumocystis
antigen model (Eddens et al., 2016). Together, these results
demonstrate for the first time that Th2 responses participate in
iBALT formation synergistically with Th17 cells in response to
fungal infection.
While mechanistic studies in the murine model clearly indicate
that natural transmission of Pneumocystis can induce iBALT for-
mation, the role for Pneumocystis in iBALT formation in humans
is unknown. Several key populations have been shown previ-
ously to develop iBALT: infants (Tschernig et al., 1995), and pa-
tients with COPD (John-Schuster et al., 2014; Litsiou et al.,
2013), asthma (Elliot et al., 2004), or pulmonary complications
of rheumatoid arthritis (Rangel-Moreno et al., 2006). Importantly,
colonization ofPneumocystis in all of these populations has been
documented. Infants are nearly ubiquitously colonized with
Pneumocystis by the age of 4 months; furthermore, Pneumocys-
tis colonization in young children correlates with the increase in
a mucus-associated gene, suggestive of a pathologic immune
response (Eddens et al., 2016; Pe´rez et al., 2014; Vargas et al.,
2013). Likewise, patients with COPD and Pneumocystis have
more severe disease and increases in proteases and inflamma-
tory markers (Fitzpatrick et al., 2014; Morris et al., 2004b; Norris
andMorris, 2011).While colonization has yet to be fully studied in
asthma, a subset of patients with severe asthma have increased
anti-Pneumocystis IgG and IgE antibodies, which correlates with
worsened disease (Eddens et al., 2016). Finally, patients with
rheumatoid arthritis can have asymptomatic colonization of
Pneumocystis, or depending on the therapeutic regimen, can
become immunosuppressed enough to develop fulminant Pneu-
mocystis pneumonia (Mori and Sugimoto, 2015; Mori et al.,
2008). In all of these pathologic conditions, the correlation be-
tween Pneumocystis colonization or infection and iBALT forma-
tion is unknown. However, future studies examining the relation-
ship between Pneumocystis and iBALT formation in humans
would be highly informative in supporting and/or validating the
findings in a murine model of Pneumocystis exposure.
EXPERIMENTAL PROCEDURES
Mice
All mouse colonies were maintained in the Rangos Research Building Animal
Facility and use was approved and performed in accordance with the Univer-
sity of Pittsburgh Institutional Care and Use Committee (Protocol: 14084329
and 16027674). C57BL/6, BALB/c, Cxcr5/, Lta/, Stat6/, Gata1tm6Sho/J,
Rag1/, and Rag2/Il2rg/ mice were all ordered from The Jackson
Laboratory. The Il17ra/ and Il17rb/ mice were generated at Amgen. The
Il17rc/ mice were generated at GenenTech. Both male and female mice
were used throughout experiments in an equal manner. Mice ranged from
6-8 weeks old, unless otherwise specified. Mice were randomized based on
cage. Sample size was determined using power calculations based on prior
experiments at day 14 post-infection that showed a 6-fold reduction in
Pneumocystis burden with a 10% SD. With a type I error rate of 0.05 and a
power of 0.90, we calculated the use of at least four mice per group.
Reagents
Mice were depleted of CD4+ cells by weekly intraperitoneal injection of 0.3 mg
of GK1.5 monoclonal antibody as previously described (Eddens et al., 2015,
2016). CD20+ cells were depleted using intraperitoneal injections of 0.1 mg
5D2 monoclonal antibody every 3 days (Elsegeiny et al., 2015). Recombinant
IL-17A and IL-13 (R&D Systems) was used at a final concentration of
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100 ng/mL. Recombinant IL-6 (R&D Systems) was used at a final concentra-
tion of 40 ng/mL.
Pneumocystis Inoculation
Pneumocystis murina was harvested from the lungs of an infected
Rag2/Il2rg/ mouse. Following straining through a 70-mm sterile filter,
mice were challenged with 2.03 106 cysts/mL as previously described (Zheng
et al., 2001, 2005). Aspergillus fumigatus inoculation was performed as
described previously (McAleer et al., 2016).
Immunofluorescence Staining and Histologic Analysis
The left lobe was fixed by injecting 10% formalin into the left main stem bron-
chus. Lung tissue was processed, paraffin-embedded, and sectioned. H&E
staining was performed by the Children’s Hospital of Pittsburgh Histology
Core. For immunofluorescence, slides were hydrated in PBS andwere blocked
for30minat roomtemperature inFcblock (10mg/mL) and5%v/vnormaldonkey
serum in PBS. Slides were then incubated with primary antibodies diluted in
0.1%Tween 20and0.1%Triton X-100dissolved inPBS for 30minat room tem-
perature to detect high endothelial venules (PNAd, clone MECA-79, BD Biosci-
ences), lymphatics (Lyve-1, Acris, DP3513), and B cell follicles (APC-CD45R/
B220, cloneRA3-6B2,BDBiosciences). Germinal centerB cellswere visualized
withacombinationofproliferatingcell nuclearantigen (PCNA,cloneC-20,Santa
Cruz Biotechnology), FITC-conjugated peanut agglutinin (PNA, L-7381-5MG,
SIGMA), and APC conjugates rat anti-mouse CD45R/B220 (clone RA3-6B2,
BD Biosciences). Antibodies specific for CD3-epsilon (clone M-20, Santa Cruz
Biotechnology) in combination with APC-CD45R/B220 were used to define B
and T cell distribution in iBALT structures. Slides were stained with a combina-
tion of antibodies specific for CD21-CD35 (clone7E9, Biolegend) and FDCM1
(551320, BD PharMingen) to detect follicular dendritic cells. Location of
CXCL13-producing cells was performed with a goat anti-mouse antibody
against CXCL13 (AF470, R&D Systems). To detect primary antibodies, we
used Cy3-goat anti-rat Ig M (112-166-075, Jackson Immunoresearch Labora-
tories), Alexa Fluor 488 donkey anti-rabbit Ig G (711-546-152, Jackson Immu-
noresearch Laboratories), Alexa Fluor 568 donkey anti-goat Ig G (A11057, Life
Technologies), Alexa Fluor 488 rabbit anti-fluorescein (A11090, Life Technolo-
gies), Alexa Fluor donkey anti-rat Ig G (A21208, Life Technologies), and Alexa
Fluor 488 streptavidin (S11223, Life Technologies). After staining, tissues were
mounted with prolong gold antifade with DAPI (P36931, Life Technologies).
Images were collected with Zeiss Axioplan 2 microscope and the outline tool
in Zeiss Axiovision softwarewas used formeasuring and enumerating lymphoid
follicles inPneumocystis infected lungs. Immunofluorescent staining and quan-
tification was performed in a blinded manner.
qRT-PCR
The rightmiddle lobewashomogenized inTrizol (Life Technologies) followedby
RNA isolation per manufacturer’s instructions. Following quantification using a
Nanodrop 2000 (Thermo Scientific), 500 ng of RNAwas converted to cDNA us-
ing iScript (Bio-Rad). Gene expression analyses were then performed using
SsoAdvanced qRT-PCR universal probes supermix (Bio-Rad). Murine primers
included: Ccl19, Ccl21, Ifng, Prg2, Il6, Il17a, and Ccl11 (Applied Biosciences)
andCxcl13, Il5, Il13, andCxcl1 (IDT).PneumocystisSSUburdenwas quantified
as described previously (Eddens et al., 2016). Hprt was used as the house-
keeping gene for calculation of relative expression and fold change.
Adoptive Transfer of CD4+ T Cells
Spleens, mediastinal lymph nodes (mLN), and lungs were isolated from
C57BL/6 mice infected with Pneumocystis for 14 days. The organs were me-
chanically digested and strained through a 70-mm filter and CD4+ cells were
isolated using an EasySep Negative selection kit (StemCell) as previously
described (Elsegeiny et al., 2015). The cells were then enumerated and
5.0 3 105 cells were transferred intravenously to Rag1/ mice previously in-
fected with Pneumocystis for 14 days. Fourteen days following transfer,
burden and gene expression was analyzed.
Ex Vivo Antigen Restimulation Assay
The right lower lobe of lung was collected, mechanically digested, and enzy-
matically digested with collagenase/DNase for 1 hr at 37C as described pre-
viously (Eddens et al., 2015, 2016). Single cell suspensions were then strained
using a 70-mm sterile filter. Red blood cells were lysed using a NH4Cl solution
and the cells were enumerated using Trypan Blue staining. Cells were then
plated at 5 3 105 cells per well, stimulated with either 5 mg Pneumocystis an-
tigen or 2.5 mL of CD3/CD28 Dynabeads (2015-07, Life Technologies).
Following 72 hr, the cells were pelleted and the supernatants were collected
and analyzed on a 7-plex T cell Luminex per manufacturer’s instructions
(Bio-Rad). The remaining cells were resuspended in Trizol LS (Life Technolo-
gies) for RNA isolation.
Anti-pneumocystis IgG ELISA
Serumwas isolated frommice at the time of sacrifice, diluted 1:64, and used in
a direct ELISA as described previously (Eddens et al., 2016).
Flow Cytometry
Whole lung cells were isolated prepared as described in the ex vivo whole lung
cell stimulationmethods. Briefly, cells were plated, centrifuged, and stimulated
with 50ng/mLPMAand750ng/mL ionomycin for 4 hr. After 1 hr, 1mLGolgiStop
(BD PharMingen) was added. Following incubation, cells were then washed
and resuspended in surfaceantibodiesdiluted inPBSat 1:200unlessotherwise
specified. Surface staining included:CD3-Alexa700 (eBioscience, clone: 17A2)
TCRb-PerCP-Cy5.5 (eBioscience, clone:H57-597), TCRgd-FITC (eBioscience,
clone: GL3), CD90.2-PE-Cy7, diluted 1:1,500 (eBioscience, clone: 53-2.1),
CD11b-Biotin (eBioscience, clone: M1/70), F4/80-biotin (eBioscience, clone:
BM8), NK1.1-biotin (BD PharMingen, clone: PK136), CD11c-biotin (BD
PharMingen, clone: HL3), CD19-biotin (BD PharMingen, clone: 1D3), and
TER119-biotin (BD PharMingen, cat: 553672). Following a 1 hr incubation at
4C, cells were washed and resuspended in the streptavidin-BV421 (diluted
1:200). Following a 30 min incubation at 4C, cells were washed and fixed
andpermeabilized using the eBioscienceFoxP3 staining kit permanufacturer’s
instructions. Intracellular antibodies, anti-IL-17A-APC (eBioscience, clone:
17B7) and anti-IL-13-PE (eBioscience, clone: eBio13A) antibodies were added
and incubated at 4C for 1 hr. Cells were then washed, resuspended, and
analyzed on a BD LSR II Flow Cytometer with compensation via OneComp
eBeads (eBioscience). Data analysis was conducted using FlowJo software
(Treestar). For sorting of pulmonary cell populations, the following antibodies
were used: anti-CD45 (eBioscience, FITC 11-0454-81 and e450 48-0454-80,
clone: 104) anti-CD31 (APC, eBioscience 17-0311-80 clone: 360), and anti-po-
doplanin (PE, eBioscience 12-5381-80 clone: 8.1.1). Cells were sorted using
FacsAriaII flow cytometer into Trizol and RNA was isolated as above.
Pulmonary Fibroblast Culture and Stimulation
Whole lung cells were isolated as described above and plated at a 1:10 dilution
in 24-well plates. Cells were incubated for 3 days at 37C to allow for adher-
ence, washed oncewith PBS, and left to grow in complete IMDMuntil reaching
50%–70%confluence. The cellswere then stimulatedwith the various cytokine
mixtures described above and incubated at 37C for 6 or 24 hr. For adenovirus-
Cre GFP (Ad-Cre) experiments, 1 mL of 2.03 1012 plaque-forming units (pfu) of
Ad-Cre was added at the point of 100% confluence and incubated at 37C for
48 hr. Cells were then washed and stimulated as described above. The cells
were then harvested in 1 mL Trizol to isolate total RNA and perform qRT-PCR.
Statistics
Eachdatapoint representsabiologic replicate. Everyexperimentwasperformed
twiceatminimum.All statistical analyseswere performedusingGraphPadPrism
version6.0f.All data arepresentedasmean±SEM.Eachgroupwasanalyzed for
outliers using the ROUT method with a Q = 1%. Studies with two groups were
analyzedwithaStudent’s t test.Studieswith threeormoregroupswereanalyzed
using an ordinary one-way ANOVA with Tukey’s multiple comparisons. Differ-
ences with a p < 0.05 were considered statistically significant.
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